TAMOXIGET

Description

Tamoxifen citrate is a non-steroidal agent that has demonstrated potent anti-oestrogenic properties in animal test systems. The anti-oestrogenic effects may be related to its ability to compete with oestrogen for binding sites in target tissues such as breast. 

Indications:

• Metastatic Breast Cancer

Tamoxifen citrate Tablets are effective in the treatment of metastatic breast cancer in women and men. In premenopausal women with metastatic breast cancer, Tamoxifen citrate Tablets are an alternative to oophorectomy or ovarian irradiation. 

• Adjuvant Treatment of Breast Cancer

Tamoxifen citrate Tablets are indicated for the treatment of node-positive breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection, and breast irradiation. 

Tamoxifen citrate Tablets are indicated for the treatment of axillary node-negative breast cancer in women following total mastectomy or segmental mastectomy, axillary dissection and breast irradiation.

The oestrogen and progesterone receptor values may help to predict whether adjuvant Tamoxifen citrate Tablets therapy is likely to be beneficial.

Tamoxifen citrate Tablets reduce the occurrence of contralateral breast cancer in patients receiving adjuvant Tamoxifen citrate Tablets therapy for breast cancer.

Available Strengths